Leukemia & lymphoma/Leukemia and lymphoma
Leukemia & lymphoma/Leukemia and lymphoma is a subscription journal published by Taylor & Francis in Switzerland. OpenAlex counts 14,278 works from it, cited 254,633 times; its h-index is 125. Its two-year mean citedness, which is computed the way the impact factor is, is 1.82: a paper it published in the two years before was cited about 1.82 times last year. It published 350 papers in 2025, about as many as in 2024.
- Publisher
- Taylor & Francis
- Citations per paper
- 1.82 two-year mean, OpenAlex
- h-index
- 125 i10-index 7,291
- Access
- Subscription
- ISSN
- 1026-8022, 1029-2403, 1042-8194
- Country
- Switzerland
- Works published
- 14,278 cited 254,633 times
- Papers in 2025
- 350
- Field
- Medicine
- Website
- Journal home ↗
Leukemia & lymphoma/Leukemia and lymphoma year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 282 | 9,039 |
| 2025 | 350 | 11,328 |
| 2024 | 334 | 12,354 |
| 2023 | 285 | 13,184 |
| 2022 | 414 | 13,097 |
| 2021 | 465 | 14,569 |
| 2020 | 543 | 13,323 |
| 2019 | 501 | 11,639 |
What Leukemia & lymphoma/Leukemia and lymphoma publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Lymphoma Diagnosis and TreatmentPathology and Forensic Medicine · 6,571 papers
- Chronic Lymphocytic Leukemia ResearchHematology · 4,244 papers
- Acute Myeloid Leukemia ResearchHematology · 3,591 papers
- Acute Lymphoblastic Leukemia researchHematology · 2,199 papers
- Viral-associated cancers and disordersOncology · 2,046 papers
Questions about Leukemia & lymphoma/Leukemia and lymphoma
What is the impact factor of Leukemia & lymphoma/Leukemia and lymphoma?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 1.82 for Leukemia & lymphoma/Leukemia and lymphoma: on average, each paper it published in the two years before was cited about 1.82 times in a year.
What is the h-index of Leukemia & lymphoma/Leukemia and lymphoma?
125, by OpenAlex's count: 125 of its papers have each been cited at least 125 times. Its i10-index is 7,291.
Is Leukemia & lymphoma/Leukemia and lymphoma open access?
Not fully. Leukemia & lymphoma/Leukemia and lymphoma is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.
What is the ISSN of Leukemia & lymphoma/Leukemia and lymphoma?
Its linking ISSN is 1026-8022; all its ISSNs: 1026-8022, 1029-2403, 1042-8194.
Who publishes Leukemia & lymphoma/Leukemia and lymphoma?
Taylor & Francis, based in Switzerland.
How many papers does Leukemia & lymphoma/Leukemia and lymphoma publish a year?
350 in 2025, by OpenAlex's count of what it published that year.
What does Leukemia & lymphoma/Leukemia and lymphoma publish?
Its most frequent research topics are Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, in the field of Medicine.
Is Leukemia & lymphoma/Leukemia and lymphoma a predatory journal?
Nothing in the scholarly indexes suggests so. Leukemia & lymphoma/Leukemia and lymphoma is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 14,278 works cited 254,633 times. For a journal you do not know, check the red flags with our predatory journal checker.
Is Leukemia & lymphoma/Leukemia and lymphoma indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (1026-8022): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Leukemia & lymphoma/Leukemia and lymphoma
Other Medicine journals with a similar impact.
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).